Vecantoxatug is a passive immunization agent with an excellent safety profile, which delivers superior protection compared with human tetanus immunoglobulin (HTIG), providing rapid and durable immune ...

The rollout of antiretroviral therapy for HIV showed how global solidarity and smart policy can overcome barriers to new ...

Research published in The Lancet HIV earlier this year, experts estimated that, if purchased at scale, the cost of generic lenacapavir could range from USD 35 to USD 46 per person-year. Falling to USD ...

Deputy Minister of Health, Dr Joe Phaahla, has hailed long-acting injectables such as Lenacapavir as a game-changer poised to revolutionise HIV prevention, especially for adolescent girls, young women ...

It's time to develop more effective ways to control and prevent sexually transmitted gut infections, urge the authors of an ...

ALBAY, Philippines – Decades ago, the fight against Human Immunodeficiency Virus (HIV) in Albay was marked by silence. Raising awareness about HIV, let alone getting tested, was seen as “filthy,” ...

Renowned HIV researcher Dr. Julio Montaner says taking BC’s HIV strategy global could save millions of lives. Photo for The Tyee by Michelle Gamage. A renowned local researcher says scaling up British ...

WASHINGTON (AP) — The U.S. is purchasing enough doses of a new twice-a-year HIV prevention shot to share with up to 2 million people in poor countries by 2028, the State Department announced Thursday.

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

WASHINGTON, United States (AFP) — The United States will fund a program for affordable access to a groundbreaking HIV prevention drug in lower-income countries, the State Department said Thursday, ...